Evidence map›Paper›PMID 37479769›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2023

What impacts do the new ESH 2023 guidelines have on the management of hypertension in Japan?

Kazuomi Kario, Satoshi Hoshide, Masaki Mogi, Akira Nishiyama, Yusuke Ohya, Koichi Node

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Hypertension Research global initiatives 2025 added new themes-"implementation hypertension" and "morning hypertension".Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  2. Hypertension treatment up-date on World Hypertension Day 2024: current status and future prospects in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan. kkario@jichi.ac.jp.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Masaki MogiDepartment of Pharmacology, Ehime University Graduate School of Medicine, Ehime, Japan.
Akira NishiyamaDepartment of Pharmacology, Kagawa University Medical School, Kagawa, Japan.
Yusuke OhyaDepartment of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Koichi NodeDepartment of Cardiovascular Medicine, Saga University, Saga, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HypertensionBlood PressureBlood Pressure Monitoring, AmbulatoryHumansJapanAmbulatory blood pressureESH 2023 guidelinesHome blood pressureHypertension management

Identifiers

PMID37479769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.